Full name
BIONORICA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
73.1 - Advertising
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,2 | 1,6 | 2,3 | 44,9 |
Gross profit (loss) | 1,4 | 1,7 | 2,4 | 35 |
EBITDA | 1,7 | 2 | 2,6 | 27,9 |
Short time liabilities | 0,4 | 0,7 | 0,7 | 6,9 |
Other operating costs | 0 | 0 | 0 | -97,6 |
Equity capital | 3 | 3,3 | 3,7 | 14,2 |
Operating profit (EBIT) | 1,4 | 1,8 | 2,3 | 33,2 |
Assets | 8,2 | 10,5 | 12,3 | 17,7 |
Net profit (loss) | 1,1 | 1,3 | 1,7 | 36,3 |
Cash | 1,9 | 3,4 | 2,9 | -14,8 |
Liabilities and provisions for liabilities | 5,1 | 7,2 | 8,6 | 19,3 |
Net income from sale | 30,4 | 37 | 48,9 | 32,2 |
Working assets | 6,7 | 8,8 | 10,5 | 18,6 |
Other income costs | 0,2 | 0,2 | 0,1 | -69,7 |
Depreciation | 0,3 | 0,2 | 0,2 | -9,7 |
% | % | % | p.p. | |
Profitability of capital | 34,5 | 39,1 | 46,7 | 7,6 |
Equity capital to total assets | 37,3 | 31,3 | 30,4 | -0,9 |
Gross profit margin | 4,7 | 4,7 | 4,8 | 0,1 |
EBITDA Margin | 5,5 | 5,4 | 5,2 | -0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 5 | 7 | 6 | -1 |
Current financial liquidity indicator | 16.592260360717773 | 12.631753921508789 | 14.015188217163086 | 1,4 |
Net dept to EBITDA | -1.152942419052124 | -1.7018439769744873 | -1.134495735168457 | 0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane